Intraveno Iron Drugs Market

Iron supplements are available in two forms: oral and intravenous. Intravenous iron preparations are superior to oral supplements, as these lead to higher and faster increase in iron and Hb levels. Oral supplements have disadvantages such as GI adverse events, poor adherence, poor gastrointestinal absorption, and non-compliance.
Intraveno Iron Drugs Market contains market size and forecasts of Intraveno(IV) Iron Drugs in global, including the following market information:
Global Intraveno(IV) Iron Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Intraveno(IV) Iron Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Intraveno(IV) Iron Drugs companies in 2021 (%)
The global Intraveno(IV) Iron Drugs market was valued at 1868.1 million in 2021 and is projected to reach US$ 2648 million by 2028, at a CAGR of 5.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Low Molecular Weight Iron Dextran Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Intraveno(IV) Iron Drugs include Allergan, AMAG Pharmaceuticals, Galenica, Actavis, American Regent, Sanofi, Luitpold Pharmaceuticals, Fresenius Medical Care and Pharmacosmos and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intraveno(IV) Iron Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intraveno(IV) Iron Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Intraveno(IV) Iron Drugs Market Segment Percentages, by Type, 2021 (%)
Low Molecular Weight Iron Dextran
Ferric Gluconate
Iron Sucrose
Ferric Carboxyl Maltose
Global Intraveno(IV) Iron Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Intraveno(IV) Iron Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Global Intraveno(IV) Iron Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Intraveno(IV) Iron Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intraveno(IV) Iron Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Intraveno(IV) Iron Drugs revenues share in global market, 2021 (%)
Key companies Intraveno(IV) Iron Drugs sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Intraveno(IV) Iron Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
AMAG Pharmaceuticals
Galenica
Actavis
American Regent
Sanofi
Luitpold Pharmaceuticals
Fresenius Medical Care
Pharmacosmos
Vifor Pharma